oRF Biologics

Funding and NIH signals

• SEC Form D raise Raised $1.73M (Form D filed Jul 31, 2026). SEC Form D 0002048350-26-000004 (Jul 31, 2026)
  Evidence (1 event)

  • Jul 31, 2026 · SEC Form D 0002048350-26-000004
    Name of Issuer: ORF Biologics, Inc.; CIK: 2048350; Address: Tiffin, IA; Submission type: D; Filing date: 2026-07-31; Industry Group: Biotechnology; Date of First Sale: 2026-07-23; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 2500000; Total Amount Sold: 1734220; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals